GIP
USNA icon

Granite Investment Partners’s Usana Health Sciences USNA Stock Holding History

Granite Investment Partners’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-66,417
Closed -$3.84M – 293
2020
Q1 		$3.84M Buy
+66,417
New +$4.62M 0.25% 106

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Granite Investment Partners's USNA Position: Q2 2020 in Review

Granite Investment Partners sold out of Usana Health Sciences (USNA) in Q2 2020, closing a stake of 66,417 shares — an estimated $3.84M sold.

Granite Investment Partners first reported a position in USNA in Q1 2020 and held it in 1 quarter. The position peaked at $3.84M in Q1 2020. 192 funds tracked by Wall St. Rank hold USNA as of Q2 2020.

  • Granite Investment Partners reported no remaining Usana Health Sciences position as of Q2 2020 after selling out during the quarter.
  • Granite Investment Partners sold 66,417 Usana Health Sciences shares in Q2 2020, an estimated $3.84M.
  • Granite Investment Partners first reported a position in Usana Health Sciences in Q1 2020 and held it in 1 quarter.
  • Granite Investment Partners's Usana Health Sciences position peaked at $3.84M in Q1 2020.
  • 192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2020.

Based on Granite Investment Partners's 13F filing for Q2 2020, filed 3 Aug 2020.